A nurse is caring for a client who has an uncomplicated lower urinary tract infection. Which of the following medication classes should the nurse anticipate for treatment?

This question focuses on the pharmacological management of simple cystitis. Knowledge of antimicrobial classifications and their specific indications for urinary tract pathogens is necessary to anticipate the correct treatment for a client with an uncomplicated lower urinary tract infection. Choice A rationale . Nitrofurantoin is a first-line antimicrobial specifically used for uncomplicated lower urinary tract infections. It concentrates in the urine to inhibit bacterial acetyl-coenzyme A, interfering with metabolism. It is effective against common uropathogens like Escherichia coli in the bladder. Choice B rationale . Pyrazinamides are antitubercular agents specifically used in the treatment of Mycobacterium tuberculosis. They have no role in treating common bacterial lower urinary tract infections and would be ineffective against the standard pathogens that cause cystitis or uncomplicated bladder inflammation. Choice C rationale . Glycopeptides, such as vancomycin, are typically reserved for severe, systemic Gram-positive infections like MRSA. They are not used for uncomplicated lower urinary tract infections, which are predominantly caused by Gram-negative bacteria that glycopeptides do not effectively target. Choice D rationale . Aminoglycosides are potent antibiotics used for serious, systemic Gram-negative infections and often require peak and trough monitoring. They are considered too toxic and broad-spectrum for an uncomplicated lower urinary tract infection, where simpler, more localized treatments are preferred.